Mentice reports Q2 2026 growth and profitability
The company announced two orders worth USD 2.4M from a top MedTech firm.
See the latest news and media coverage for Mentice. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical simulation solutions for image-guided interventional therapies
mentice.comLast updated
In short: Mentice reported strong Q2 2026 growth, secured a $2.4 million order from a top MedTech firm, and partnered with Siemens Healthineers.
The company announced two orders worth USD 2.4M from a top MedTech firm.
Net sales grew 25.5% to 79.6 MSEK, EBITDA improved to 6.3 MSEK, and order intake rose 36.6%.
It allows importing real patient aneurysm DICOM data for procedural simulation in under five minutes.
The orders are for simulation solutions in interventional cardiology focused on structural heart disease.
Jul. 27 Pareto Securities raises its price target for Mentice to 14 kronor (13.50), reiterates hold FW ...
Mentice AB (FRA:MN2) reports a 28% revenue increase and significant order intake growth, driven by strategic initiatives and partnerships.
Mentice, which is a supplier of simulation technology for surgeons, reports an EBITDA result for the second quarter of 2026 of SEK 6.3 million (-8.1).
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage...
Track Mentice and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Mentice and other trending companies.